I-Mab Inc. - Rasio nilai perusahaan marang dodolan IMAB

Simbol resmi perusahaan I-Mab Biopharma Co., Ltd. (IMAB)

The EV/Sales valuation, as shown in this chart on GURU.Markets, demonstrates the business value-to-sales dynamics, where is recorded as the baseline value. I-Mab is building a global oncology network by combining its own biologics with international expertise. The development of targeted antibodies creates a long-term technological foundation for profit. The specifics of the medical sector guarantee capital stability regardless of macroeconomic fluctuations.

I-Mab Biopharma (IMAB): Nilai perusahaan marang pendapatan saka 04.07.2022 nganti 20.11.2026

I-Mab Biopharma - rincian analitis lan metrik utama (IMAB)

Pambiji fundamental perusahaan:IMAB, I-Mab Inc.
Produk sing diprodhuksi i-mabbiopharma.com

The EV/Sales metric determines the enterprise value of the business relative to generated revenue. For I-Mab (IMAB), this indicator reflects the efficiency of capitalizing innovations in immuno-oncology. By analyzing the current EV/Sales level, an investor identifies valuation deviations from historical averages. This is critical given the massive R&D expenditures required for antibody development. The indicator's range confirms the fundamental stability of the asset.

Analisis pesaing

Multiplikator nilai perusahaan marang pendapatan Incyte Corporation|HCM (HUTCHMED Corp) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Nuvation Pharma NUVB|Nilai perusahaan marang pendapatan DAWN|Multiplikator nilai perusahaan marang pendapatan Monopar Therapeutics MNPR|Nilai perusahaan marang pendapatan INBX (Inhibrx Biosciences)|FENC (Fennec Pharmaceuticals Inc.) - Nilai bisnis marang pendapatan|Heron Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan NVCT (Nuvectis Pharma)|Coherus BioSciences, Inc. - Multiplikator EV/Sales|Nilai bisnis marang pendapatan CRBP (Corbus Pharma)|CRDF: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan beyondspringpharma.com (BYSI)|Rasio nilai perusahaan marang pendapatan bioatla.com|LIXT: Nilai bisnis marang pendapatan|Multiplikator EV/Sales CTXR|Multiplikator EV/Sales Cellectar Corp (CLRB)|Rasio nilai perusahaan marang pendapatan BioLineRx Corp BLRX|CANF (Can-Fite BioPharma Ltd.) - Nilai perusahaan marang volume dodolan|APRE: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Kazia Therapeutics Limited|Silexion Therapeutics Corp (SLXN) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan NCNA|CMRX (Chimerix, Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cyclacel Pharmaceuticals CYCC|G1 Therapeutics Inc. (GTHX) - Nilai bisnis marang pendapatan|KRON - Multiplikator nilai perusahaan marang pendapatan|Kintara Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan ONCT (Oncternal)|Portage Biotech Corp - Multiplikator EV/Sales